Related Experiment Video
Updated: Jul 15, 2025
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Novel mechanisms of MITF regulation and melanoma predisposition identified in a mouse suppressor screen
Hong Nhung Vu1, Matti Már Valdimarsson2, Sara Sigurbjörnsdóttir1
1Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102 Reykjavík, Iceland.
Abstract:
MITF, a basic-Helix-Loop-Helix Zipper (bHLHZip) transcription factor, plays vital roles in melanocyte development and functions as an oncogene. To explore MITF regulation and its role in melanoma, we conducted a genetic screen for suppressors of the Mitf-associated pigmentation phenotype. An intragenic Mitf mutation was identified, leading to termination of MITF at the K316 SUMOylation site and loss of the C-end intrinsically disordered region (IDR). The resulting protein is more nuclear but less stable than wild-type MITF and retains DNA-binding ability. Interestingly, as a dimer, it can translocate wild-type and mutant MITF partners into the nucleus, improving its own stability and ensuring an active nuclear MITF supply. Interactions between K316 SUMOylation and S409 phosphorylation sites across monomers largely explain the observed effects. Notably, the recurrent melanoma-associated E318K mutation in MITF, which affects K316 SUMOylation, also alters protein regulation in concert with S409, unraveling a novel regulatory mechanism with unexpected disease insights.
Insights
A novel MITF mutation reveals how the microphthalmia-associated transcription factor (MITF) is regulated. This discovery sheds light on melanoma development and offers new insights into protein interactions and nuclear transport.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and acts as an oncogene in melanoma.
- Understanding MITF regulation is key to exploring its role in melanoma progression.
Approach:
- A genetic screen identified suppressors of Mitf-associated pigmentation defects.
- An intragenic mutation in Mitf was discovered, leading to MITF protein truncation at the K316 SUMOylation site.
- The study analyzed the effects of this mutation on MITF nuclear localization, stability, and DNA-binding activity.
Key Points:
- Truncated MITF is more nuclear but less stable, yet retains DNA-binding capacity.
- MITF dimers can facilitate nuclear translocation of both wild-type and mutant MITF, enhancing stability and nuclear supply.
- Interplay between K316 SUMOylation and S409 phosphorylation sites across monomers is critical for MITF regulation.
Conclusions:
- A novel regulatory mechanism for MITF involving SUMOylation and phosphorylation has been uncovered.
- The recurrent melanoma mutation E318K impacts K316 SUMOylation, revealing new disease insights.
- This research provides a deeper understanding of MITF function and its implications in melanoma.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:23Abnormal Proliferation
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
01:16In-vitro Mutagenesis